Results 11 to 20 of about 40,704 (257)

Impact of beta-lactam allergy labels on antibiotic prophylaxis and surgical site infections after cesarean section; a retrospective study [PDF]

Antimicrobial Resistance and Infection Control
Background Reported beta-lactam allergies often lead to avoidance of first-line antibiotics and may increase surgical complications. Cesarean sections (CSs), where prophylactic antibiotics are universally administered, offer a unique setting to assess ...
Mudrik-Zohar Hadar, Chowers Michal, Kovo Michal, Shechter-Maor Gil, Shitrit Pnina, Pnina Shitrit   +5 more
doaj   +3 more sources

Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology [PDF]

Allergy, Asthma & Clinical Immunology, 2020
The vast majority of individuals labelled as allergic are not deemed truly allergic upon appropriate assessment by an allergist. A label of beta-lactam allergy carries important risks for individual and public health. This article provides an overview of
Samira Jeimy, Moshe Ben-Shoshan, Elissa M. Abrams, Anne K. Ellis, Lori Connors, Tiffany Wong   +5 more
doaj   +3 more sources

Antibiotic use and financial impact of a comprehensive beta-lactam allergy management program [PDF]

Antimicrobial Stewardship & Healthcare Epidemiology
Objective: A multidisciplinary beta-lactam allergy management program was implemented at our community medical center to facilitate allergy documentation, conduct penicillin skin testing (PST), and decrease non-beta-lactam (NBL) use.
Karan Raja, Lakhini Vyas, Susan Morrison, Donald Beggs, Mitesh Patel, Mona Philips   +5 more
doaj   +3 more sources

Beta-lactam antibiotics administration among adult inpatients with a beta-lactam allergy label: incidence, predictors, and outcomes [PDF]

Antimicrobial Stewardship & Healthcare Epidemiology
Background: A beta-lactam antibiotics (BLA) allergy label is common, resulting in disadvantageous outcomes due to the usage of second-line antimicrobial agents.
Naama Epstein-Rigbi, Sharon Ziv, Marina Bulanenkova, Ruth Bouganim, Ruthy Tal-Jasper, Dror Marchaim   +5 more
doaj   +3 more sources

Beta-Lactam Allergy De-labeling in a Pediatric Hospital. [PDF]

J Pediatr Pharmacol Ther
OBJECTIVE To assess the ability to de-label pediatric patients of their beta-lactam allergy by using a newly implemented institutional protocol and to identify potential barriers to the de-labeling process. METHODS All patients with reported ...
Meehl S, Salathe C, Cooley C, Jordan-Villegas A, Laham FR, Madala A, Cowart M.   +6 more
europepmc   +4 more sources

Safety of direct oral provocation in beta-lactam allergy

Allergologia et Immunopathologia
N ...
Öner Özdemır
semanticscholar   +5 more sources

Clinical Outcome Associated With Beta‐Lactam Allergy Labels in Hospitalized Patients in Belgium

Clinical and Translational Allergy
Background In the United States, beta‐lactam allergy labels (BLAL) are documented in 9%–16% of hospitalized patients and associated with worse clinical outcomes such as increased mortality, length of hospital stay (LOS), intensive care unit (ICU ...
Liesbeth Gilissen, Greet Van De Sijpe, Annouschka Laenen, Peter Declercq, Dries Wets, Ileana Ghiordanescu, Anca Mirela Chiriac, Willy E. Peetermans, Paul De Munter, Isabel Spriet, Rik Schrijvers   +10 more
doaj   +3 more sources

Is the Anamnesis Enough to De-Label Patients with Reported Beta-Lactam Allergy? [PDF]

J Clin Med
Background: The decision whether to de-label patient with suspected BL hypersensitivity is based on risk stratification. The aim of this study was to prepare a characteristic of diagnostic risk groups and to create a model enabling the identification of ...
Rozłucka L, Rymarczyk B, Gawlik R, Glück J.   +3 more
europepmc   +4 more sources

An algorithm for the diagnosis of beta‐lactam allergy, 2024 update [PDF]

Allergy
Open access publishing facilitated by Universidad de Málaga/CBUA This study has been supported by the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofounded by European Regional Development Fund: PI21/00329; and through its programme of Redes de Investigacion Cooperativa Orientadas al Resultado en Salud ...
Inmaculada Doña, María Salas, Esther Moreno, Marta Ferrer, Cristobalina Mayorga, Marı́a José Torres   +5 more
semanticscholar   +5 more sources

Can Beta-Lactam Allergy De-Labeling Strategies Safely Empower Geriatric Care? [PDF]

J Clin Med
Background: Drug allergies constitute a significant health concern among the elderly, with beta-lactam (BL) antibiotics among the most frequently implicated agents.
Goldhaber G, Confino-Cohen R, Lachover-Roth I, Cohen-Engler A, Sity-Harel S, Rosman Y.   +5 more
europepmc   +4 more sources